{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:31:59Z","timestamp":1783567919946,"version":"3.55.0"},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T00:00:00Z","timestamp":1399852800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Opioid switching or rotation is reported to be a common practice in palliative care. Published tables of opioid conversion ratios have been found to vary in their recommendations, potentially leading to significant differences in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To identify common practices in the calculation of opioid equianalgesia by specialist palliative medicine practitioners and trainees.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>An anonymous, cross\u2010sectional, online survey completed by 85 <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ustralian palliative care specialists or advanced trainees. Questions focused on conversion ratios used in switching between oral and parenteral opioid doses; conversion ratios used when switching from other opioids to oral morphine; and practice of commencing methadone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The majority of respondents calculated equianalgesic doses for morphine, oxycodone and hydromorphone using the same conversion ratios. Methadone was used almost equally as either the sole opioid or as a \u2018co\u2010opioid\u2019. The majority surveyed converted slow\u2010release hydromorphone differently to the manufacturer's recommendations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Further discussion among <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ustralian palliative care specialist organisations is recommended in order to produce uniform conversion guidelines to improve consistency and safety in the prescribing of opioids.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.12401","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T11:45:50Z","timestamp":1393847150000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Opioid conversion ratios used in palliative care: is there an Australian consensus?"],"prefix":"10.1111","volume":"44","author":[{"given":"W.","family":"Syrmis","sequence":"first","affiliation":[{"name":"St Vincent's Private Hospital Brisbane University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Good","sequence":"additional","affiliation":[{"name":"St Vincent's Private Hospital Brisbane, Mater Health Services University of Queensland  Brisbane Queensland Australia"},{"name":"Mater Research Institute University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wootton","sequence":"additional","affiliation":[{"name":"St Vincent's Private Hospital Brisbane University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Spurling","sequence":"additional","affiliation":[{"name":"Discipline for General Practice, School of Medicine University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.12.024"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00271-8"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.06.001"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.06.002"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00294-9"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/15360280802537241"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.06.004"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb139323.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1191\/096813098673619329"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(96)03286-1"},{"key":"e_1_2_7_12_1","first-page":"93","article-title":"Methadone\u2010 an alternative conversion regime","volume":"9","author":"Blackburn D","year":"2002","journal-title":"Eur J Palliat Care"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216308089302"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00204.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1680"},{"key":"e_1_2_7_16_1","volume-title":"Palliative Care Formulary. 3rd ed.","author":"Twycross R","year":"2007"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200207001-00002"},{"key":"e_1_2_7_18_1","first-page":"833","article-title":"Content development for European Guidelines on the use of opioids for cancer pain: a systematic review and Expert Consensus Study","volume":"76","author":"Pigni A","year":"2010","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216309346595"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.01.010"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/J354v18n04_03"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311406577"},{"key":"e_1_2_7_23_1","unstructured":"MIMS Online Full Prescribing Information; Oxycontin [Internet]. [cited 2014 Mar 19]. Available from URL:https:\/\/www.mimsonline.com.au\/Search\/AbbrPI.aspx?ModuleName=Product%20Info&searchKeyword=oxycontin&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=47800001_2"},{"key":"e_1_2_7_24_1","first-page":"75","article-title":"A new extended release formulation, (OROS) of hydromorphone in the management of pain","volume":"5","author":"Weinstein S","year":"2009","journal-title":"Ther Clin Risk Manage"},{"key":"e_1_2_7_25_1","unstructured":"MIMS Online Full Prescribing Information; Dilaudid [Internet]2010. [cited 2010 Oct]. Available from URL:https:\/\/www.mimsonline.com.au\/Search\/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=dilaudid&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=49100001_2"},{"key":"e_1_2_7_26_1","unstructured":"MIMS Online Full Prescribing Information; Jurnista [Internet]2010. [cited 2010 Oct 22]. Available from URL:https:\/\/www.mimsonline.com.au\/Search\/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=jurnista&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=82560001_2"},{"key":"e_1_2_7_27_1","first-page":"129","volume-title":"Advances in Pain Research and Therapy","author":"Houde R","year":"1986"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200210000-00013"},{"key":"e_1_2_7_29_1","unstructured":"MIMS Online Full Prescribing Information; Durogesic [Internet]2010. [cited 2010 Oct]. Available from URL:https:\/\/www.mimsonline.com.au\/Search\/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=durogesic&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=37940001_2"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00095-5"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.005"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0546-6"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00378.x"},{"key":"e_1_2_7_34_1","unstructured":"National Prescribing Service Limited.Position Statement December 2009 Quality use of over\u2010the\u2010counter codeine [Internet].2009. [cited 2010 Nov]. Available from ULR:http:\/\/www.nps.org.au\/news_and_media\/position_statements\/codeine"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-1-1"},{"key":"e_1_2_7_36_1","volume-title":"Opioids in Cancer Pain","author":"Hardy JR","year":"2009"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199236640.001.0001"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-004-0720-4"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00060-3"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/15360280802251199"},{"key":"e_1_2_7_41_1","volume-title":"Palliative Care Formulary","author":"Twycross R","year":"2007"},{"key":"e_1_2_7_42_1","volume-title":"Therapeutic Guidelines: Palliative Care","author":"Ravenscroft P","year":"2010"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2008\/11\/S133"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199236640.001.0001"},{"key":"e_1_2_7_45_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/J354v19n02_03","article-title":"Intermittent subcutaneous methadone administration in the management of cancer pain","volume":"19","author":"Centeno C","year":"2005","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"e_1_2_7_46_1","first-page":"216","article-title":"Prescribing methadone, a unique analgesic","volume":"1","author":"Manfredi PL","year":"2003","journal-title":"J Support Oncol"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2008.00461.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2012.9605"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimj.12401","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.12401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:03:31Z","timestamp":1696208611000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.12401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1111\/imj.12401"],"URL":"https:\/\/doi.org\/10.1111\/imj.12401","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"2013-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-02-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}